60 related articles for article (PubMed ID: 38701267)
1. FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer.
Huang Z; Wang Z; Xu C; Yan Y; Cao X; Zhang F; Shen B
Int J Med Sci; 2024; 21(8):1447-1460. PubMed ID: 38903931
[No Abstract] [Full Text] [Related]
2. A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer.
Yan Z; Liu Y; Wang M; Wang L; Chen Z; Liu X
Sci Rep; 2024 Jun; 14(1):14667. PubMed ID: 38918587
[TBL] [Abstract][Full Text] [Related]
3. Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer.
Zhang X; Hong B; Li H; Zhao J; Li M; Wei D; Wang Y; Zhang N
BMC Cancer; 2024 Jun; 24(1):746. PubMed ID: 38898429
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis-related lncRNAs: Distinguishing heterogeneity of the tumour microenvironment and predicting immunotherapy response in bladder cancer.
Yang Z; Li X; Zhou L; Luo Y; Zhan N; Ye Y; Liu Z; Zhang X; Qiu T; Lin L; Peng L; Hu Y; Pan C; Sun M; Zhang Y
Heliyon; 2024 Jun; 10(11):e32018. PubMed ID: 38867969
[TBL] [Abstract][Full Text] [Related]
5. A novel mitochondrial-related lncRNA signature mediated prediction of overall survival, immune landscape, and the chemotherapeutic outcomes for bladder cancer patients.
Xiong H; Lin C; Huang X; Wang H
Discov Oncol; 2024 Jun; 15(1):239. PubMed ID: 38907134
[TBL] [Abstract][Full Text] [Related]
6. Integrative Single Cell Atlas Revealed Intratumoral Heterogeneity Generation from an Adaptive Epigenetic Cell State in Human Bladder Urothelial Carcinoma.
Xiao Y; Jin W; Qian K; Ju L; Wang G; Wu K; Cao R; Chang L; Xu Z; Luo J; Shan L; Yu F; Chen X; Liu D; Cao H; Wang Y; Cao X; Zhou W; Cui D; Tian Y; Ji C; Luo Y; Hong X; Chen F; Peng M; Zhang Y; Wang X
Adv Sci (Weinh); 2024 Jun; 11(24):e2308438. PubMed ID: 38582099
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer.
Zhou L; Du K; Dai Y; Zeng Y; Luo Y; Ren M; Pan W; Liu Y; Zhang L; Zhu R; Feng D; Tian F; Gu C
J Transl Med; 2024 Jan; 22(1):55. PubMed ID: 38218866
[TBL] [Abstract][Full Text] [Related]
8. Identification of cuproptosis-related long non-coding RNA and construction of a novel prognostic signature for bladder cancer: An observational study.
Ye Z; Liu C; Wu S; Jin X; Lin H; Wang T; Zheng Q; Guo Z
Medicine (Baltimore); 2024 May; 103(18):e38005. PubMed ID: 38701267
[TBL] [Abstract][Full Text] [Related]
9. An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.
Sun Z; Jing C; Xiao C; Li T
Aging (Albany NY); 2020 Aug; 12(15):15624-15637. PubMed ID: 32805727
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma.
Zhu S; Li H; Fan Y; Tang C
BMC Urol; 2023 Jul; 23(1):124. PubMed ID: 37479989
[TBL] [Abstract][Full Text] [Related]
11. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer.
Bai Y; Zhang Q; Liu F; Quan J
Front Immunol; 2022; 13():1027449. PubMed ID: 36451815
[TBL] [Abstract][Full Text] [Related]
12. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
Bao Z; Zhang W; Dong D
Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
[TBL] [Abstract][Full Text] [Related]
13. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
